Swiss pharmaceutical behemoth Roche Holdings (OTCMKTS ADR: RHHBF) couldn't wait until Monday to announce its biggest deal in five years.
Sunday, the healthcare giant said it is buying California-based biotech company InterMune Inc. (Nasdaq: ITMN) in an $8.3 billion all-cash transaction.